Table 3.
Tumor marker | Calcium (mmol/L) | CEA (ng/mL) | CA125 (U/mL) | CA153 (U/mL) | CA199 (U/mL) | CYFRA21-1 (ng/mL) | NSE (μg/L) | TPSA (ng/L) |
---|---|---|---|---|---|---|---|---|
LM group | 2.23 ± 0.23 | 104.05 ± 233.30 | 164.30 ± 360.52 | 32.14 ± 70.44 | 150.75 ± 731.14 | 15.96 ± 40.17 | 48.43 ± 77.88 | 1.75 ± 1.80 |
NLM group | 2.24 ± 0.26 | 58.46 ± 307.30 | 79.20 ± 183.50 | 22.30 ± 33.24 | 55.21 ± 528.00 | 11.69 ± 35.79 | 26.54 ± 38.83 | 1.81 ± 4.18 |
P value | 0.771 | 0.02 | 0.003 | 0.072 | 0.097 | 0.142 | <0.001 | 0.867 |
Note: independent t-test was performed. P < 0.05 revealed statistical significance. Abbreviations: CEA: carcinoembryonic antigen; CA125: cancer antigen-125; CA153: cancer antigen-153; CA199: carbohydrate antigen-199; CYFRA21-1: cytokeratin fraction 21-1; NSE: neuron-specific enolase; TPSA: total prostate-specific antigen; LM: liver metastasis; NLM: nonliver metastasis.